|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2005-10-10
|
|
pubmed:abstractText |
Vascular endothelial growth factor-C (VEGF-C) plays an important role in lymphangiogenesis and activates VEGF receptor-3 (VEGFR-3). Lymphatic spread is an important prognostic factor in patients with lung adenocarcinoma. The aim of the current study was to determine whether the expression of VEGF-C and VEGFR-3 correlates with clinicopathologic factors and prognosis in patients with TNM classification T1 lung adenocarcinoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2005 American Cancer Society
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1668-77
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:16116610-Adenocarcinoma,
pubmed-meshheading:16116610-Adult,
pubmed-meshheading:16116610-Aged,
pubmed-meshheading:16116610-Antigens, CD34,
pubmed-meshheading:16116610-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:16116610-Endothelium, Vascular,
pubmed-meshheading:16116610-Female,
pubmed-meshheading:16116610-Humans,
pubmed-meshheading:16116610-Immunoenzyme Techniques,
pubmed-meshheading:16116610-Lung Neoplasms,
pubmed-meshheading:16116610-Male,
pubmed-meshheading:16116610-Middle Aged,
pubmed-meshheading:16116610-Neoplasm Staging,
pubmed-meshheading:16116610-Prognosis,
pubmed-meshheading:16116610-Serine Endopeptidases,
pubmed-meshheading:16116610-Survival Rate,
pubmed-meshheading:16116610-Tryptases,
pubmed-meshheading:16116610-Vascular Endothelial Growth Factor A,
pubmed-meshheading:16116610-Vascular Endothelial Growth Factor C,
pubmed-meshheading:16116610-Vascular Endothelial Growth Factor Receptor-3
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
|
|
pubmed:affiliation |
Department of Respiratory Medicine, Obihiro Kyokai Hospital, Obihiro, Japan.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
